ArticleFrontiers in neurology
Prevalence and associated factors of self-reported lifetime epilepsy symptoms in an older population in Russia: the Ural Very Old Study.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The study aimed to explore the prevalence of self-reported lifetime epilepsy symptoms (SLESs) and associated factors among an elderly population in Russia. Methods: The population-based Ural Very Old Study (UVOS) was conducted in Bashkortostan, Russia. Of 1882 eligible inhabitants aged 85 + years, 1,526 (81.1%) participated, including 389 (25.5%) men and 1,137 (74.5%) women. The participants underwent a detailed medical examination and interview, during which a history of epileptic attacks was assessed using standardized questions. Results: Of the 1,526 participants, 1,523 (99.9%), with a mean age of 88.8 ± 2.9 years (range: 85.0-103.1 years), provided information on epilepsy-related questions during the interview. A history of self-reported lifetime epilepsy symptoms was found in 23 individuals (1.5%; 95% confidence interval (CI): 0.90, 2.12), including 4 (17%) men. The mean age of these individuals was 89.2 ± 3.8 years (85.0-103.1 years). In a multivariable analysis, a higher prevalence of self-reported lifetime epilepsy symptoms was associated with a higher prevalence of neck pain (OR:3.53;95%CI:1.35,9,22; Conclusion: Self-reported lifetime epilepsy symptoms, experienced at any period of life and assessed using a questionnaire with standardized questions, were reported by 23 of 1,523 participants (1.5%) in this very old population in Bashkortostan. The prevalence was independent of sex, educational level, ethnic background, rural versus urban region of habitation, diabetes mellitus, and arterial hypertension.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.